Opyl Limited (ASX:OPL – Get Free Report) insider Antanas (Tony) Guoga bought 1,500,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The shares were purchased at an average cost of A$0.03 ($0.02) per share, with a total value of A$45,000.00 ($27,950.31).
Opyl Price Performance
Opyl Company Profile
Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials.
Read More
- Five stocks we like better than Opyl
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is the Euro STOXX 50 Index?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How to Most Effectively Use the MarketBeat Earnings Screener
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Opyl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opyl and related companies with MarketBeat.com's FREE daily email newsletter.
